• Explore /
  • Poster
  • / Association of HER2/CEP17 ratio with pCR after HER2-directed neoadjuvant treatments in the phase III NeoALTTO trial.

Association of HER2/CEP17 ratio with pCR after HER2-directed neoadjuvant treatments in the phase III NeoALTTO trial.

Abstract Poster

Authors

null

Christian F. Singer

Klinische Abteilung für Allgemeine Gynäkologie und Gynäkologische Onkologie, Comprehensive Cancer Center - Universitätsklinik für Frauenheilkunde Medizinische Universität Wien / AKH, Wien, Vienna, Austria

Christian F. Singer , Franz König , Stephanie Kacerovsky-Strobl , Sabine Danzinger , Christine Brunner , Christoph Suppan , Christine Deutschmann , Marija Balic , Richard Greil , Daniel Egle , Evandro de Azambuja , Serena Di Cosimo , Michael Gnant

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Breast Cancer—Local/Regional/Adjuvant

Track

Breast Cancer

Sub Track

Neoadjuvant Therapy

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 600)

DOI

10.1200/JCO.2023.41.16_suppl.600

Abstract #

600

Poster Bd #

430

Abstract Disclosures

Similar Posters

First Author: Sandra M. Swain

First Author: Luca Gianni

First Author: Jens Bodo Huober

First Author: Alexios Matikas